GeoVax Labs, Inc.
GOVX
$0.7578
-$0.0251-3.21%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | 14.44% | 22.40% | 22.40% | 56.04% |
| Gross Profit | -- | 4.64% | -5.47% | -5.47% | -53.90% |
| SG&A Expenses | -- | -10.58% | -15.21% | -15.21% | -2.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 8.81% | 12.88% | 12.88% | 39.04% |
| Operating Income | -- | 5.98% | -0.23% | -0.23% | -37.52% |
| Income Before Tax | -- | 3.75% | -2.37% | -2.37% | -39.33% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | 3.75% | -2.37% | -2.37% | -39.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 3.75% | -2.37% | -2.37% | -39.33% |
| EBIT | -- | 5.98% | -0.23% | -0.23% | -37.52% |
| EBITDA | -- | 6.07% | -0.11% | -0.11% | -37.56% |
| EPS Basic | -- | 57.55% | 33.76% | 33.76% | -11.70% |
| Normalized Basic EPS | -- | 57.55% | 33.76% | 33.76% | -11.70% |
| EPS Diluted | -- | 57.55% | 33.76% | 33.76% | -11.70% |
| Normalized Diluted EPS | -- | 57.55% | 33.76% | 33.76% | -11.70% |
| Average Basic Shares Outstanding | -- | 196.46% | 94.02% | 94.02% | 30.27% |
| Average Diluted Shares Outstanding | -- | 196.46% | 94.02% | 94.02% | 30.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |